Answers are grounded in this paper and cite their sources.
Inherited retinal diseases are a leading cause of blindness in working age adults in many countries. X-linked retinitis pigmentosa (RP) accounts for a significant proportion, with the majority associated with pathogenic variants in the RPGR gene.1 Although currently untreatable, two Phase 3 gene therapy trials are ongoing (NCT04850118 and NCT04671433). Patients experience debilitating restriction of visual field,2 but a key additional milestone is the subsequent loss of central vision. We collected visual acuity (VA) data from the large patient cohort with molecularly proven RPGR-associated RP in our centre, aiming to quantify average VA for each decade, specifically identifying the decade in which this declined to 1.0 LogMAR or worse.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: